Ironwood Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $90,545 | $91,592 | $94,396 | $74,877 |
Gross Profit | 90,545 | 91,592 | 93,890 | 74,364 |
EBITDA | 33,394 | 27,295 | 26,852 | 12,702 |
EBIT | 32,909 | 26,788 | 26,346 | 12,189 |
Net Income | 2,256 | 31,092 | -860 | -4,162 |
Net Change In Cash | 90,545 | 91,592 | 94,396 | 74,877 |
Free Cash Flow | 15,214 | 9,869 | 33,407 | 44,917 |
Cash | 88,559 | 88,211 | 105,524 | 121,540 |
Basic Shares | 160,419 | 160,232 | 159,014 | 157,700 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $351,410 | $442,735 | $410,596 | $413,753 |
Gross Profit | 351,410 | 337,950 | 409,178 | 412,230 |
EBITDA | 100,243 | -924,864 | 261,438 | 233,330 |
EBIT | 98,232 | -926,439 | 260,020 | 231,807 |
Net Income | 880 | -1,002,239 | 175,065 | 528,448 |
Net Change In Cash | 351,410 | 442,735 | 410,596 | 413,753 |
Cost of Revenue | 36,074 | 257,080 | ||
Free Cash Flow | 103,407 | 183,154 | 273,627 | 261,630 |
Cash | 88,559 | 92,154 | 656,203 | 620,129 |
Basic Shares | 160,084 | 155,435 | 186,312 | 164,418 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.02 |
2024-09-30 | $0.02 |
2024-06-30 | -$0.005 |
2024-03-31 | -$0.02 |
